Volume 115, Issue 3
ARTICLE

3D aggregate culture improves metabolic maturation of human pluripotent stem cell derived cardiomyocytes

Cláudia Correia

iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal

Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal

Search for more papers by this author
Alexey Koshkin

iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal

Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal

Search for more papers by this author
Patrícia Duarte

iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal

Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal

Search for more papers by this author
Dongjian Hu

Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts

Harvard Medical School, Boston, Massachusetts

Harvard Stem Cell Institute, Cambridge, Massachusetts

Search for more papers by this author
Madalena Carido

iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal

Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal

Search for more papers by this author
Maria J. Sebastião

iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal

Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal

Search for more papers by this author
Patrícia Gomes‐Alves

iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal

Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal

Search for more papers by this author
David A. Elliott

Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, Australia

Search for more papers by this author
Ibrahim J. Domian

Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts

Harvard Medical School, Boston, Massachusetts

Harvard Stem Cell Institute, Cambridge, Massachusetts

Search for more papers by this author
Ana P. Teixeira

Corresponding Author

E-mail address: anat@ibet.pt

iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal

Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal

Correspondence

Margarida Serra and Ana P. Teixeira, Animal Cell Technology Unit, iBET, Instituto de Biologia Experimental e Tecnológica and Instituto de Tecnologia Química e Biológica, Apartado 12, 2781–901 Oeiras, Portugal.

Email: mserra@ibet.pt (M.S); anat@ibet.pt (A.P.T)

Search for more papers by this author
Paula M. Alves

iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal

Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal

Search for more papers by this author
Margarida Serra

Corresponding Author

E-mail address: mserra@ibet.pt

iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal

Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal

Correspondence

Margarida Serra and Ana P. Teixeira, Animal Cell Technology Unit, iBET, Instituto de Biologia Experimental e Tecnológica and Instituto de Tecnologia Química e Biológica, Apartado 12, 2781–901 Oeiras, Portugal.

Email: mserra@ibet.pt (M.S); anat@ibet.pt (A.P.T)

Search for more papers by this author
First published: 27 November 2017
Citations: 25
Present address of Ana P. Teixeira is ETH Zurich, Department of Biosystems Science and Engineering, Mattenstrasse 26, 4058 Basel, Switzerland.

Abstract

Three‐dimensional (3D) cultures of human pluripotent stem cell derived cardiomyocytes (hPSC‐CMs) hold great promise for drug discovery, providing a better approximation to the in vivo physiology over standard two‐dimensional (2D) monolayer cultures. However, the transition of CM differentiation protocols from 2D to 3D cultures is not straightforward. In this work, we relied on the aggregation of hPSC‐derived cardiac progenitors and their culture under agitated conditions to generate highly pure cardiomyocyte aggregates. Whole‐transcriptome analysis and 13C‐metabolic flux analysis allowed to demonstrate at both molecular and fluxome levels that such 3D culture environment enhances metabolic maturation of hiPSC‐CMs. When compared to 2D, 3D cultures of hiPSC‐CMs displayed down‐regulation of genes involved in glycolysis and lipid biosynthesis and increased expression of genes involved in OXPHOS. Accordingly, 3D cultures of hiPSC‐CMs had lower fluxes through glycolysis and fatty acid synthesis and increased TCA‐cycle activity. Importantly, we demonstrated that the 3D culture environment reproducibly improved both CM purity and metabolic maturation across different hPSC lines, thereby providing a robust strategy to derive enriched hPSC‐CMs with metabolic features closer to that of adult CMs.

Number of times cited according to CrossRef: 25

  • Glucose metabolism regulates expression of hair-inductive genes of dermal papilla spheres via histone acetylation, Scientific Reports, 10.1038/s41598-020-61824-3, 10, 1, (2020).
  • Metabolic environment in vivo as a blueprint for differentiation and maturation of human stem cell-derived cardiomyocytes, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 10.1016/j.bbadis.2020.165881, (165881), (2020).
  • A Brief Review of Current Maturation Methods for Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes, Frontiers in Cell and Developmental Biology, 10.3389/fcell.2020.00178, 8, (2020).
  • Modeling Cardiovascular Diseases with hiPSC-Derived Cardiomyocytes in 2D and 3D Cultures, International Journal of Molecular Sciences, 10.3390/ijms21093404, 21, 9, (3404), (2020).
  • Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine, Nature Reviews Cardiology, 10.1038/s41569-019-0331-x, (2020).
  • Toward Cardiac Regeneration: Combination of Pluripotent Stem Cell-Based Therapies and Bioengineering Strategies, Frontiers in Bioengineering and Biotechnology, 10.3389/fbioe.2020.00455, 8, (2020).
  • Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies, Cardiovascular Research, 10.1093/cvr/cvaa125, (2020).
  • The roles of human induced pluripotent stem cell-derived cardiomyocytes in drug discovery: managing in vitro safety study expectations, Expert Opinion on Drug Discovery, 10.1080/17460441.2020.1736549, (1-11), (2020).
  • Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes, World Journal of Stem Cells, 10.4252/wjsc.v11.i1.34, 11, 1, (34-44), (2019).
  • Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes, World Journal of Stem Cells, 10.4252/wjsc.v11.i1.33, 11, 1, (33-43), (2019).
  • Modelling of Genetic Cardiac Diseases, Visions of Cardiomyocyte - Fundamental Concepts of Heart Life and Disease [Working Title], 10.5772/intechopen.79311, (2019).
  • Transcriptomic analysis of 3D Cardiac Differentiation of Human Induced Pluripotent Stem Cells Reveals Faster Cardiomyocyte Maturation Compared to 2D Culture, Scientific Reports, 10.1038/s41598-019-45047-9, 9, 1, (2019).
  • Unveiling the molecular crosstalk in a human induced pluripotent stem cell‐derived cardiac model, Biotechnology and Bioengineering, 10.1002/bit.26929, 116, 5, (1245-1252), (2019).
  • Genomics Analysis of Metabolic Pathways of Human Stem Cell-Derived Microglia-Like Cells and the Integrated Cortical Spheroids, Stem Cells International, 10.1155/2019/2382534, 2019, (1-21), (2019).
  • Bioreactor-based 3D human myocardial Ischemia/Reperfusion in vitro model: a novel tool to unveil key paracrine factors upon AMI., Translational Research, 10.1016/j.trsl.2019.09.001, (2019).
  • Cell population balance of cardiovascular spheroids derived from human induced pluripotent stem cells, Scientific Reports, 10.1038/s41598-018-37686-1, 9, 1, (2019).
  • Human pluripotent stem cell-derived cardiomyocytes for studying energy metabolism, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 10.1016/j.bbamcr.2019.04.001, (2019).
  • Human cardiac progenitor cell activation and regeneration mechanisms: exploring a novel myocardial ischemia/reperfusion in vitro model, Stem Cell Research & Therapy, 10.1186/s13287-019-1174-4, 10, 1, (2019).
  • Phenotypic variation between stromal cells differentially impacts engineered cardiac tissue function, Tissue Engineering Part A, 10.1089/ten.TEA.2018.0362, (2019).
  • Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications, Cells, 10.3390/cells8050403, 8, 5, (403), (2019).
  • Expansion Culture of Human Pluripotent Stem Cells and Production of Cardiomyocytes, Bioengineering, 10.3390/bioengineering6020048, 6, 2, (48), (2019).
  • 3D Cardiac Cell Culture: A Critical Review of Current Technologies and Applications, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2019.00087, 6, (2019).
  • Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Drug-Induced Inotropic Effects in Early Drug Development. Part 2: Designing and Fabricating Microsystems for Assaying Cardiac Contractility With Physiological Relevance Using Human iPSC-Cardiomyocytes, Frontiers in Pharmacology, 10.3389/fphar.2019.00934, 10, (2019).
  • Metabolic Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibition of HIF1α and LDHA, Circulation Research, 10.1161/CIRCRESAHA.118.313249, 123, 9, (1066-1079), (2018).
  • Oxygen transporter for the hypoxic transplantation site, Biofabrication, 10.1088/1758-5090/aaf2f0, 11, 1, (015011), (2018).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.